All Nobel Prizes

All Nobel Prizes

2011

THE NOBEL PRIZE IN PHYSICS
Saul Perlmutter, Brian P. Schmidt, Adam G. Riess

THE NOBEL PRIZE IN CHEMISTRY
Dan Shechtman

THE NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE
Bruce A. Beutler, Jules A. Hoffmann, Ralph M. Steinman

THE NOBEL PRIZE IN LITERATURE
Tomas Tranströmer

THE NOBEL PEACE PRIZE
Ellen Johnson Sirleaf, Leymah Gbowee, Tawakkol Karman

THE PRIZE IN ECONOMIC SCIENCES
Thomas J. Sargent, Christopher A. Sims

2010

THE NOBEL PRIZE IN PHYSICS
Andre Geim, Konstantin Novoselov

THE NOBEL PRIZE IN CHEMISTRY
Richard F. Heck, Ei-ichi Negishi, Akira Suzuki

THE NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE
Robert G. Edwards

THE NOBEL PRIZE IN LITERATURE
Mario Vargas Llosa

THE NOBEL PEACE PRIZE
Liu Xiaobo

THE PRIZE IN ECONOMIC SCIENCES
Peter A. Diamond, Dale T. Mortensen, Christopher A. Pissarides

2009

THE NOBEL PRIZE IN PHYSICS
Charles Kuen Kao, Willard S. Boyle, George E. Smith

THE NOBEL PRIZE IN CHEMISTRY
Venkatraman Ramakrishnan, Thomas A. Steitz, Ada E. Yonath

THE NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE
Elizabeth H. Blackburn, Carol W. Greider, Jack W. Szostak

THE NOBEL PRIZE IN LITERATURE
Herta Müller

THE NOBEL PEACE PRIZE
Barack H. Obama

THE PRIZE IN ECONOMIC SCIENCES
Elinor Ostrom, Oliver E. Williamson

2008

THE NOBEL PRIZE IN PHYSICS
Yoichiro Nambu, Makoto Kobayashi, Toshihide Maskawa

THE NOBEL PRIZE IN CHEMISTRY
Osamu Shimomura, Martin Chalfie, Roger Y. Tsien

THE NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE
Harald zur Hausen, Françoise Barré-Sinoussi, Luc Montagnier

THE NOBEL PRIZE IN LITERATURE
Jean-Marie Gustave Le Clézio

THE NOBEL PEACE PRIZE
Martti Ahtisaari

THE PRIZE IN ECONOMIC SCIENCES
Paul Krugman

NIPER JEE Questions :

Which fatty is biosynthesized by human body(N-10)
a)Stearic acid
b)Oleic acid
c)Linoleic acid
d)Linolenic acid

RBI nationalized in(N-09)
a)1951
b)1950
c)1949
d)1935

When HBr is added to styrene according to antimarkonikove rule,what product?(N-2010)
a)C6H5CHBrCH3
b)C6H5CH2CH2Br
c)C6H5CH2CH3
d) None of these

In which State AYUSH (AYURVEDIC, YOGA, UNANI, HOMOPATHY,) is established?(N-10)
a) Himachal Pradesh
b) Utterakhand
c) Kerla
d) M.P

Which of the following alpha glucosidase inhibitor is polysaccharide?(N)
(a)miglitol
(b)viglibiose
(c)acarbose
(d) glucogol.

Which receptor has heptahelical structure? (N)
(a) metabotropic
(b)tyrosine kinase
(c)ionotropic
(d)nuclear

Which of the following is inverse agonist? (N)
(a) beta carboline
(b)cannabinoids
(c)none of the above
(d)all of the above

Which of the following cephalosporin has disulfiram like effect? (N)
(a) cefixime
(b) cefaperazone
(c) cefuroxime
(d)cefamandole

Full forms List

Full Form List :

UDV Unit Dose Vial UKECA United Kingdom Ethics Committee Authority USP United States Pharmacopoeia WIPO World Intellectual Patent Office TGA Therapeutic Goods Administration, Australia TMF Trial Master File SARS Severe Acute Respiratory Syndrome SCDM Society for Clinical Data Management SIDS Sudden Infant Death Syndrome SIGAR Special Interest Group on Adverse Reactions R&D Research and Development RAPS Regulatory Affairs Professionals Society RCT Randomised Clinical Trials RDE Remote Data Entry RDS Research Defence Society REC Research Ethics Committee RGN Registered General Nurse RPSGB Royal Pharmaceutical Society of Great Britain RSM Royal Society of Medicine Rx Prescription QA Quality Assurance QSM-WHO Quality Assurance and Safety of Medicines (WHO) PDS Pharmacoepidemiology and Drug Safety (journal) PEM Prescription Event Monitoring PHRMA Pharmaceutical Research and Manufacturers Association PIL Package Insert Leaflet PMDA Pharmaceuticals and Medical Devices Agency, Japan PMS Post-Marketing Surveillance POM Prescription Only Medicine PSM Procurement and Supply Management PSUR Periodic Safety Update Report NAFDAC National Agency for Food and Drug Administration and Control, Nigeria NCPA National Community of Pharmacist Association NCPO National Conference of Pharmaceutical Organisations NDA New Drug Application NDMS National Disaster Medical System NME New Molecule Entity NSAID Non-Steroidal Anti-Inflammatory Drug IACUC Institutional Animal Care and Use Committee IAES Institutional Animal Ethics Committee ICDRA International Conference for Drug Regulatory Authorities ICH International Conference on Harmonization IIG Inactive Ingredient Guide  IMP Investigational Medicinal Products IMP - Investigational Medicinal Products IMPD Investigational Medicinal Product Dossier INDA Investigational New Drug Application INN International non-proprietary names (for pharmaceutical substances) INTDIS International Drug Information System - the previous WHO adverse reactions database IPC Indian Pharmaceutical Congress IPGA Indian Pharmacy Graduate Association ISO International Organization for Standardization ISoP International Society of Pharmacovigilance ISPE International Society for Pharmacoepidemiology HIS Indian Health Services  HPLC High Performance Liquid Chromatography HRSA Health Resources & Service Administration GCP Good Clinical Practices GLP Good Laboratory Practices GMP Good Manufacturing Practices FDA Food & Drug Administration FIP International Pharmaceutical Federations DRA Drug Regulatory Affairs DUMP Disposal of Unwanted Medicines and Poisons CADD Computer Aided Drug Design CDC Centre for Disease Control CIOMS Council for International Organisations of Medical Sciences CPCSEA Committee for Purpose of Control & Supervision of Experimental Animals CPI Consumer Price Index  CRA Clinical Research Associate CRC Clinical Research Council CRF Case Report Form CRN Clinical Research Network CRO Contract Research Organisation CSM Committee on Safety of Medicine CTC Clinical Trials Centre BMA British Medical Association BMJ British Medical Journal BPC Bulk Pharmaceutical Chemicals BPI British Pharmaceutical Index BrAPP British Association of Pharmaceutical Physicians AAAS American Association of Advancement of Science AALAS American Association for Laboratory Animal Science AIDS Acquired Immune Deficiency Syndrome  AIOPI Association of Information Officers of the Pharmaceutical Industry ALF American Liberation Front ANDA Abbreviated New Drug Application

Intellectual Property Rights:

 Intellectual Property Rights: Some Imp Points

• A patent is an exclusive right granted for an invention, which is a product or a process that provides, in general, a new way of doing something, or offers a new technical solution to a problem.  In order to be patentable, the invention must fulfill certain conditions.
• Trademarks are distinctive signs, used to differentiate between identical or similar goods and services offered by different producers or services providers. Trademarks are a type of industrial property, protected by intellectual property rights. 
• An industrial design is the ornamental or aesthetic aspect of an article. The design may consist of three-dimensional features, such as the shape or surface of an article, or of two-dimensional features, such as patterns, lines or color.
• A geographical indication (GI) is a sign used on goods that have a specific geographical origin and possess qualities, reputation or characteristics that are essentially attributable to that origin. An appellation of origin (AO) is a special kind of GI.
• Copyright and related rights protect the rights of authors, performers, producers and broadcasters, and contribute to the cultural and economic development of nations. This protection fulfills a decisive role in articulating the contributions and rights of different stakeholders and the relation between them and the public. The purpose of copyright and related rights is twofold: to encourage a dynamic creative culture, while returning value to creators so that they can lead a dignified economic existence, and to provide widespread, affordable access to content for the public.

FDA Approval Drugs-2012

FDA Approval Drugs-2012

Dermatology/Plastic Surgery

Erivedge (vismodegib); Genentech; For the treatment of basal cell carcinoma, Approved January 2012

Picato (ingenol mebutate) gel; LEO Pharma; For the treatment of actinic keratosis, Approved January 2012

Sklice (ivermectin) lotion; Sanofi Pasteur; For the treatment of head lice, Approved February 2012

Endocrinology

Bio-T-Gel (testosterone gel); Teva Pharmaceuticals; For the treatment of hypogonadism, Approved February 2012

Elelyso (taliglucerase alfa); Pfizer Inc; For the treatment of Gaucher disease, Approved May 2012

Jentadueto (linagliptin plus metformin hydrochloride); Eli Lilly; For the treatment of type II diabetes, Approved February 2012

Korlym (mifepristone); Corcept Therapeutics; For the control of hyperglycemia in adults with endogenous Cushing’s syndrome, Approved February 2012

Ultresa (pancrelipase) delayed-release capsules; Aptalis Pharma; For the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions, Approved March 2012

Viokace (pancrelipase) tablets; Aptalis Pharma; For the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy, Approved March 2012

Gastroenterology

Elelyso (taliglucerase alfa); Pfizer Inc; For the treatment of Gaucher disease, Approved May 2012

Ultresa (pancrelipase) delayed-release capsules; Aptalis Pharma; For the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions, Approved March 2012

Viokace (pancrelipase) tablets; Aptalis Pharma; For the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy, Approved March 2012

Hematology

Elelyso (taliglucerase alfa); Pfizer Inc; For the treatment of Gaucher disease, Approved May 2012

Omontys (peginesatide); Affymax; For the treatment of anemia due to chronic kidney disease, Approved March 2012

Immunology/Infectious Diseases

Qnasl (beclomethasone dipropionate) nasal aerosol; Teva Pharmaceuticals; For the treatment of seasonal and perennial allergic rhinitis, Approved March 2012

Musculoskeletal

Elelyso (taliglucerase alfa); Pfizer Inc; For the treatment of Gaucher disease, Approved May 2012

Neupro (Rotigotine Transdermal System); UCB; For the treatment of Restless Legs Syndrome, Approved April 2012

Stendra (avanafil); Vivus; For the treatment of erectile dysfunction, Approved April 2012

Votrient (pazopanib); GlaxoSmithKline; For the treatment of soft tissue sarcoma, Approved April 2012

Nephrology/Urology

Afinitor (everolimus); Novartis Pharmaceuticals Corporation; For the treatment of renal angiomyolipoma associated with tuberous sclerosis complex, Approved April 2012

Inlyta (axitinib); Pfizer; For the treatment of advanced renal cell carcinoma, Approved January 2012

Omontys (peginesatide); Affymax; For the treatment of anemia due to chronic kidney disease, Approved March 2012

Stendra (avanafil); Vivus; For the treatment of erectile dysfunction, Approved April 2012

Voraxaze (glucarpidase); BTG International; For the treatment of toxic plasma methotrexate concentrations in patients with impaired renal function, Approved January 2012

Neurology

Neupro (Rotigotine Transdermal System); UCB; For the treatment of Restless Legs Syndrome, Approved April 2012

Subsys (fentanyl sublingual spray); Insys Therapeutics; For the treatment of breakthrough cancer pain, Approved January of 2012

Obstetrics/Gynecology

Natazia (estradiol valerate and estradiol valerate/dienogest); Bayer HealthCare; For the treatment of heavy menstrual bleeding, Approved March 2012

Oncology

Afinitor (everolimus); Novartis Pharmaceuticals Corporation; For the treatment of renal angiomyolipoma associated with tuberous sclerosis complex, Approved April 2012

Erivedge (vismodegib); Genentech; For the treatment of basal cell carcinoma, Approved January 2012

Inlyta (axitinib); Pfizer; For the treatment of advanced renal cell carcinoma, Approved January 2012

Picato (ingenol mebutate) gel; LEO Pharma; For the treatment of actinic keratosis, Approved January 2012

Subsys (fentanyl sublingual spray); Insys Therapeutics; For the treatment of breakthrough cancer pain, Approved January of 2012

Votrient (pazopanib); GlaxoSmithKline; For the treatment of soft tissue sarcoma, Approved April 2012

Ophthalmology

Zioptan (tafluprost ophthalmic solution); Merck; For the treatment of elevated intraocular pressure, Approved February 2012

Otolaryngology

Dymista (azelastine hydrochloride and fluticasone propionate); Meda Pharmaceuticals Inc.; For the relief of symptoms of seasonal allergic rhinitis, Approved May 2012

Qnasl (beclomethasone dipropionate) nasal aerosol; Teva Pharmaceuticals; For the treatment of seasonal and perennial allergic rhinitis, Approved March 2012

Pediatrics/Neonatology

Qnasl (beclomethasone dipropionate) nasal aerosol; Teva Pharmaceuticals; For the treatment of seasonal and perennial allergic rhinitis, Approved March 2012

Sklice (ivermectin) lotion; Sanofi Pasteur; For the treatment of head lice, Approved February 2012

Surfaxin (lucinactant); Discovery Laboratories; For the treatment of respiratory distress syndrome in premature infants, Approved March 2012

Pharmacology/Toxicology

Voraxaze (glucarpidase); BTG International; For the treatment of toxic plasma methotrexate concentrations in patients with impaired renal function, Approved January 2012

Pulmonary/Respiratory Diseases

Dymista (azelastine hydrochloride and fluticasone propionate); Meda Pharmaceuticals Inc.; For the relief of symptoms of seasonal allergic rhinitis, Approved May 2012

Kalydeco (ivacaftor); Vertex Pharmaceuticals; For the treatment of cystic fibrosis with the G551D mutation in the CFTR gene, Approved January of 2012

Qnasl (beclomethasone dipropionate) nasal aerosol; Teva Pharmaceuticals; For the treatment of seasonal and perennial allergic rhinitis, Approved March 2012

Surfaxin (lucinactant); Discovery Laboratories; For the treatment of respiratory distress syndrome in premature infants, Approved March 2012

Rheumatology

Stendra (avanafil); Vivus; For the treatment of erectile dysfunction, Approved April 2012

List of Laboratories in INDIA

§  BCG Vaccine Lab- Chennai

§  Central drug testing lab- Mumbai

§  Central drug Laboratory- Kolkatta

§  Central Drug Research Institute - Lucknow

§  Central Research Institute- Kasauli

§  Indian Drug Manufactures Association- Mumbai

§  Indian Society of Blood Trensfusion & Immunoheamatology- Pune

§  Indian Veterinary Research Institute- Izatnagar

§  Central Indian Pharmacoepia Laboratory- Ghaziabad

§  National Plasma Fractionation Centre- Mumbai

§  National Institute for Communicable Disease- New Delhi

§  Indian Institute for Virology- Pune

§  Organization of Pharmaceutical Procedures- Mumbai

§  Dabur Research foundaion- Ghaziabad

§  Institute of applied man power research- New Delhi

§  CD Testing Lab- Mumbai

§  Synthetic Drug Plant- Hyderabad

§  National Institute of Nutrition - Hyderabad